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Abstract
Apolipoprotein E4 (ApoE4) is one of three (E2, E3 and E4) human isoforms of an α-helical, 299-amino-acid
protein. Homozygosity for the ε4 allele is the major genetic risk factor for developing late-onset Alzheimer's
disease (AD). ApoE2, ApoE3 and ApoE4 differ at amino acid positions 112 and 158, and these sequence
variations may confer conformational differences that underlie their participation in the risk of developing AD.
Here, we compared the shape, oligomerization state, conformation and stability of ApoE isoforms using a
range of complementary biophysical methods including small-angle x-ray scattering, analytical ultracentri-
fugation, circular dichroism, x-ray fiber diffraction and transmission electron microscopy We provide an in-
depth and definitive study demonstrating that all three proteins are similar in stability and conformation.
However, we show that ApoE4 has a propensity to polymerize to form wavy filaments, which do not share the
characteristics of cross-β amyloid fibrils. Moreover, we provide evidence for the inhibition of ApoE4 fibril
formation by ApoE3. This study shows that recombinant ApoE isoforms show no significant differences at the
structural or conformational level. However, self-assembly of the ApoE4 isoform may play a role in
pathogenesis, and these results open opportunities for uncovering new triggers for AD onset.
Crown Copyright © 2019 Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Background
Alzheimer's disease (AD) is the most prevalent
dementia, and the sporadic, late-onset form com-
prises 95% of all AD cases. Diagnosis is based on the
observation of specific brain pathology of extracellular
amyloid plaques composed of amyloid-beta (Aβ)
peptide and intracellular neurofibrillary tangles formed
by tau [1]. The biggest risk factor for developing AD is
age, but the ε4 variant of the apolipoprotein E (APOE)
gene is the strongest genetic risk factor for the
development of late-onset AD. The human APOE
gene encodes three major protein isoforms, ApoE2,
ApoE3 or ApoE4, that differ from one another at
amino acid positions 112 and 158. While E2 contains
two cysteine residues, E3 contains a cysteine and an
arginine, and E4 contains two arginine residues at
both sites, respectively [2]. ApoE4 presents a risk in a
gene dose-dependent manner, with ε3/ε4 heterozy-
gotes having a risk increased by three times and ε4/ε4
homozygotes having up to 15 times more chance of
developing AD [3]. ApoE3 is the most common
isoform, associated with a neutral risk. ApoE2 is
under-represented in the population but is thought to
be associated with a lower propensity for AD [4].
ApoE is a predominantly α-helical protein with 299
amino acids that is mainly produced in the liver and by
astrocytes in the brain, as well as neurons particularly
under stress conditions [5,6]. ApoE is a component of
lipoprotein particles [7] and associates with cholesterol,
triglycerides and phospholipids [8]. It is found in the
central nervous system participating in high-density
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lipoproteins and in plasma associated with very low-
density lipoproteins, chylomicron remnants and high-
density lipoprotein [9]. It has been suggested that the
ApoE isoforms have different lipid binding preferences
and that lipid binding may be mediated by a conforma-
tional change of the monomer [10]. The ApoE isoform
amino acid substitutions are presumed to affect ApoE
structure and function and have been suggested to be
responsible for ApoE4 homozygotes increased risk for
AD [11]. However, the mechanism(s) whereby ApoE4
confers an increased risk of developingAD, whether by
a loss-of-function or a gain-of-toxic-function, remains
poorly understood. It has been shown that ApoE forms
complexeswithAβ through regionswithin their heparin-
binding sites in vitro [12] and was found to be
associated with Aβ senile plaques in human brain
[13] as well as with neurofibrillary tangles [14].
Histopathological examination of post-mortem AD
brains found a positive correlation between plaque
density and dosage of the ε4 allele [14–16], and
positron emission tomography studies matched these
findings with ε4 carriers having higher Aβ deposition
compared to non-carriers [17,18]. ApoE4 has therefore
been suggested to enhance Aβ fibrillization and reduce
Aβ clearance, which is thought to contribute to AD
progression [19]. Especially, aggregated forms of
ApoE4 seem to enhanceAβ fibrillization and antibodies
that specifically recognize non-lipidated and aggregat-
ed ApoE have been shown to reduce Aβ deposition in
APPPS1-21/APOE4 mice [20]. Recent work has also
shown that human ApoE4 transgenic animals have
increased deposition of tau compared toApoE3human
transgenics [21] indicating a link to accumulation of
neurofibrillary tangles. In addition, human-induced
pluripotent stem cell-derived neurons expressing
ApoE4 were shown to have higher levels of tau
phosphorylation as well as increased degeneration of
GABAergic neurons that could be rescued by gene
editing and converting ApoE4 into ApoE3 [22].
The NMR structure of full-length ApoE3 reveals a
large, predominantly α-helical globular protein, with a
flexible C-terminal region composed of a short helix
(270–277) followed by an unstructured tail (residues
277–299) [23]. The structures for N-terminal domains
for ApoE2 and ApoE3 have been solved by x-ray
crystallography [24,25] and show α-helical bundles,
which map closely to the N-terminal domain of E3. It
has been proposed that the amino acid substitutions
lead to lowered thermal and chemical stability of
ApoE4 and higher propensity to form stable interme-
diate unfolding states characteristic ofmoltenglobules
arising from the formation of a salt-bridge that links the
C and N-terminal domain in ApoE4 [26]. A potential
consequence of this instability would be an enhanced
proteolysis of ApoE4 in neurons, generating frag-
ments that may interfere with cytoskeletal compo-
nents such as tau protein and neurofilaments [27, 28].
Decreased stability and molten globule formation has
additionally been suggested to drive ApoE4 to form
toxic, fibril-like oligomers from full-length protein,
whereas ApoE2 and ApoE3 do not appear to form
high-molecular-weight species [29].
Here we conducted an in-depth comparison of the
structure and stability of the three recombinantly
expressed and purified ApoE isoforms using state-
of-the-art biophysical techniques and explored
ApoE4's intrinsic property to oligomerize and aggre-
gate. In contrast to previous studies [25,26], we show
that the three recombinant isoforms share very similar
quaternary, tertiary and secondary structures and
thermal and chemical stability. We reveal that
recombinant ApoE4 forms fibrillar structures, howev-
er, the resulting curvilinear fibrils are fragile and do not
share the typical characteristics of cross-β amyloid.
Furthermore, to investigate theApoE4dose-effect, we
explored the effect of co-assembly of ApoE3 and E4.
The presence of ApoE3 resulted in decreased rate of
ApoE4 self-assembly and an inhibition of elongation
to long filamentous structures.
Results
All three ApoE isoforms show similar size and
shape
We have developed a method to produce and
maintain full-length ApoE proteins recombinantly (see
Materials and Methods and [30]), and it was therefore
necessary to first fully characterise these proteins.
Initial purification confirmed that ApoE2, E3 and E4
have identical mobilities of 34 kDa by non-reducing
sodium dodecylsulfate (SDS)–polyacrylamide gel
electrophoresis (PAGE; Fig. S1). Gel filtration and
size exclusion chromatography (SEC) coupled with
multi-angle light scattering (SEC-MALS) showedmulti-
merization of all three proteins consistent with a
tetramer in solution with a molecular weight (MW) of
139–151 kDa (Fig. 1a and b, Table 1). A hydrodynamic
radius of 5.8–6.5 nm was calculated for each isoform,
and a frictional ratio f/f0 above 1.7 suggests elongated
shape for the homotetramers (Table 1). Analytical
ultracentrifugation (AUC) was used to investigate the
size and shape in solution in further detail. As we
extensively dialyzed or buffer exchanged ApoE
isoforms into phosphate buffer (PB) prior to stability
and aggregation studies, we were interested if dialysis
affected ApoE oligomerization in solution. We there-
fore compared sedimentation in the original size
exclusion buffer and in PB after dialysis. AUC revealed
no differences in sedimentation velocity between the
three isoforms in either buffer (Fig. S3, Fig. 1c and d,
Table 2a), and the major species was characterized
with a molecular mass of 130 kDa (Table 2a).
Small-angle x-ray scattering (SAXS) was used to
explore whether the tetramers of the ApoE isoforms
differ in dimensions and shape. All three proteins
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exhibited identical scattering profiles indicating that
they are very similar in shape (Fig. 2a–c). A radius of
gyration (RG) of 5.6 nm (56 Å) was calculated using
the Guinier approximation and comes close to the
hydrodynamic radius determined in the other tech-
niques (Table 2b). The Kratky plot indicates that
ApoE consists of several domains that are tethered
by linkers with extended conformation. This elongat-
ed shape is reproduced in the pair distance
distribution function and fits to a maximal dimension
of approximately 19.5 nm (195 Å) (Fig. 2d).
Together AUC, SEC-MALS and SAXS show that
the three ApoE isoforms are similar in size, shape
and multimerization, and all form tetrameric species
in solution.
ApoE2, E3 and E4 are conformationally similar
and show only marginal differences in stability
Circular dichroism (CD) spectroscopy and trypto-
phan fluorescence were used to probe potential
Table 1. Parameters evaluated by gel filtration and SEC-
MALS
ApoE2, ApoE3 and ApoE4
Gel filtrationa Mw (kDa) 333
Rs (nm) 5.8
f/f0 = RS/Rmin 1.71
D (cm2 s−1) × 10−7 2.47
ApoE2 ApoE3 ApoE4
SEC-
MALSa
Mw (kDa) 144 139 151
Rs (nm) 6.55 6.4 6.81
f/f0 = RS/Rmin 1.93 1.88 2.00
D (cm2 s−1) × 10−7 3.78 3.88 3.64
a Values calculated at peak elution volume.
Fig. 1. Characterization of recombinant ApoE2, E3 and E4. (a) The SEC elution pattern of ApoE isoforms on the
Superdex 200 column as a function of absorbance at 280 nm versus the elution volume. All ApoE isoforms have a minor
elution peak at 131 mL and a major at 151 mL suggesting the presence of different oligomeric species. A hydrodynamic
radius of 5.8 nm, as well as a diffusion coefficient of 2.47 × 10−7 cm s−1 is calculated by calibration of the Superdex 200
column (inlet) using commercially available protein standards (1, ferritin; 2, aldolase; 3, conalbumin; 4, ovalbumin). A
frictional ratio f/f0 = RS/Rmin of 1.71 is calculated, which suggest moderate elongation of ApoE [31]. (b) SEC-MALS plotted
with the differential refractive index (RIU; line) are shown as a function of elution time for ApoE2, ApoE3 and ApoE4. Inset
shows the calculated molecular weight (MW) across the peak. All ApoE isoforms have identical elution volumes, and a MW
of 145, 139 and 151 kDa is calculated at elution peak for ApoE2, ApoE3 and ApoE4, respectively. (c and d) AUC showing
continuous c(S) size distributions in size exclusion buffer [20 mM Hepes, 300 mM NaCl and 10 % (v/v) glycerol pH 8.0; (c)]
and in 20 mM PB (pH 7.4; (d). No difference between ApoE isoforms is observed in either buffer condition. A major species
with a sedimentation coefficient S at 3 and 5 is observed in size exclusion and PB buffer, respectively. The difference in
sedimentation coefficient between buffers is due to the presence of glycerol in the SEC buffer.
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differences in secondary and tertiary structures of
the three isoforms. Negligible spectral differences
were observed, suggesting no major conformational
differences between the three proteins (Fig. 3a and
b). Analysis of CD spectra using Dichroweb [34, 35,
36] showed that the three isoforms all possessed
around 58% α-helical content (Table 3), with no
significant differences between them (one-way
ANOVA: F(2,9)=4.197, p N 0.05).
Folding stability of ApoE proteins was examined
using thermal and chemical denaturation and moni-
tored using CD and tryptophan fluorescence. Thermal
denaturation monitored using CD at 222 nm showed a
sigmoidal unfolding curve for all three isoforms. A
Fig. 2. SAXS. X-ray scattering curves and the dimensionless Kratky plot (ScÅtter) for ApoE2 (a), ApoE3 (b) and ApoE4
(c) are shown, as well as their corresponding pair distance distribution function (d) P(r). (a–c) All ApoE isoforms have
identical scattering profiles and adopt an extended conformation in solution with some intrinsic level of flexibility as
assessed by the dimensionless Kratky plot. (d) This extended conformation is seen in the P(r) distribution, respectively,
and a maximal dimension Dmax of approximately 19.5 nm (195 Å) is determined for each isoform.
Table 2a. Sedimentation analysis of recombinant ApoE isoforms
Buffer Frictional ratioa Sedimentation velocity (S)b Estimated MW (kDa)b Peak integration (%)b Overall RMSD valuec
SEC ApoE2 1.75 3.11 122 ~90.7 0.003370
ApoE3 1.77 3.26 129 ~70.3 0.003085
ApoE4 1.8 3.11 127 ~89.5 0.002772
PB ApoE2 1.77 5.07 127 ~84 0.003275
ApoE3 1.81 5.10 128 ~88 0.002749
ApoE4 1.74 5.23 130 ~86.5 0.002789
a Best-fitt frictional ratio used to calculate continuous size distribution.
b Corresponding to the main sedimentation peak.
c The RMSD provide evidence for the goodness of the fit. Sedimentation analysis of recombinant ApoE isoforms shows that all three
ApoE isoforms exist in a tetrameric form in size exclusion buffer [SEC; 20 mM Hepes, 300 mMNaCl, 10 % (v/v) glycerol; pH 8.0] and in 20
mM PB (pH 7.4) according to their estimated MW in solution.
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phenomenological Boltzman sigmoidal curvewas fitted
to the data and revealed that ApoE3 and ApoE4 have
similar melting temperatures of 52.39 °C and 51.32 °C,
respectively, compared to the apparent higher melting
temperature for ApoE2 of 60.28 °C (Fig. 3c(i)).
However, despite these slight differences in the
apparentmid-pointmelting temperature, no differences
were observed at physiological temperature of 37°C.
One-way ANOVA provided evidence of no significant
difference in themean ellipticity at 222 nm between the
three isoforms at 37 °C (F(2,9) = 0.9426, p = 0.4249;
Table 4a). The curves showing fraction unfolded
protein for each isoform calculated based on the fitted
sigmoidal curves allow direct comparison of the
estimated temperature unfolding transitions (Figs. 3c
(ii) and S4A), showing similar thermal denaturation
profile for all three isoforms. Furthermore, the fraction
unfolded at 37°C showed that there were no significant
differences between the three isoforms at physiological
temperature, consistent with the mean ellipticity at 222
nm at the same temperature (Table 4b).
Chemical denaturation in guanidium hydrochloride
(GuHCl) was performed in reducing conditions (1 mM
dithiothreitol), and the wavelength of maximum fluo-
rescence emission intensity λmax was plotted against
corresponding concentrations of GuHCl. All three
denaturation curves demonstrate multi-phasic behav-
ior and a two-state unfolding model did not fit the
denaturation data. Instead, a three-state unfolding
model was fitted to the data (Fig. 3d(i)), suggesting
the existence of at least three different states of the
protein, and the existence of one or more intermediate
states. The data are, therefore, consistent with the
separate unfolding of two protein domains. From the
fitted curves, GuHCl concentrations corresponding to
the midpoint of each transition were calculated (Table
4c). Similar to the thermal denaturation study, fraction
unfolded curves were calculated for each isoform in
order to directly compare the shape of the chemical
denaturation profile (Fig. 3d(ii)). The transition from a
folded state to an intermediate state occurs at a slightly
lower GuHCl concentration for ApoE4, suggesting that
the first domain to unfold denatures marginally more
easily for ApoE4 than ApoE2 and ApoE3 (0.58 M
versus ~0.71 M). ApoE3 and ApoE4 show similar
unfolding of the second domain, while ApoE2 is more
stable (~2.65 M versus 2.84 M). Overall, the observed
increased chemical denaturant concentration and
temperature needed for ApoE2 to unfold compared
with ApoE3 and E4 infers that ApoE2 has a slight
increased resistance to denaturation compared to E3
and E4, although the difference in apparent stability is
marginal (Table 4c).
ApoE4 assembles to form non-amyloid, native-
like fibers
To further investigate the behavior of the ApoE
isoforms, the three proteins were incubated in 20
mM PB at 37 °C for 24 h. Native PAGE showed that
ApoE2 and E3 ran consistently at a similar mobility at
0 h and after a 24-h incubation. However, ApoE4
Table 2b. Evaluation of the SAXS data by ATSAS and ScÅtter
ApoE2 ApoE3 ApoE4
ATSAS ScÅtter ATSAS vScÅtter ATSAS ScÅtter
Gunier analysis
Guinier Rg, (Å) 56.35 ± 0.15 56.34 ± 0.63 56.69 ± 0.14 56.81 ± 0.59 57.64 ± 0.15 57.69 ± 0.66
Gunier I(0), arbitrary units 0.25 ± 0.00049 0.28 ± 0.00044 0.25 ± 0.0004 0.25 ± 0.00034 0.24 ± 0.00041 0.24 ± 0.0063
P(r) analysis (manual)
P(r) Rg, (Å) 58.20 ± 0.08 57.56 ± 1.88 58.56 ± 0.088 57.78 ± 1.88 59.33 ± 0.067 58.46 ± 1.33
P(r) I(0), arbitrary units 0.28 ± 0.00035 0.27 ± 0.0094 0.25 ± 0.32 0.25 ± 0.0086 0.24 ± 0.00028 0.24 ± 0.0063
Dmax, (Å) 194.5 194.5 195 195 195.5 195.5
q range, (Å−1) 0.0089 - 0.2513 0.0083 - 0.2461 0.0056 -0.2414 0.0054 - 0.2394 0.0058 - 0.235 0.0056 - 0.2351
GNOM total estimate 0.92 – 0.922 – 0.929 –
χ2 (Sk2) – 1.17 (0.33) – 0.88 (0.37) – 1.02 (0.42)
P(r) analysis (Autognom)
P(r) Rg, (Å) 58.48 ± 0.12 – 58.69 ± 0.11 – 59.52 ± 0.13 –
P(r) I(0), arbitrary units 0.28 ± 0.00046 – 0.25 ± 0.00037 – 0.2415 ± 0.00039 –
Dmax, (Å) 204.68 – 203.65 – 207.92 –
q range, (Å−1) 0.0054 – 0.1419 – 0 . 0 0 5 4 –
0.1401
– 0.0056 – 0.1383 –
GNOM total estimate 0.896 – 0.899 – 0.856 –
Volume of correlation (Vc) and MW estimate
Volume of correlationVc, (Å
2)a – 1062 – 1068 – 1103
MW estimate (kDa)
b – 159 ± 5 – 160 ± 5 – 169 ± 4
Parameters were calculated for comparison in ATSAS 2.8.2 and ScÅtter 3.1R.
a P(r)-based Vc.
b Mass estimates based on P(r) Rg and Vc [2].
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formed higher MW species prior to and following
incubation. By 24 h, the majority of the ApoE4
protein formed higher oligomers that did not run
through the gel indicating oligomerization of the
ApoE4 protein (Fig. 4a). Thioflavin T (ThT) fluores-
cence assay is frequently used to monitor molecular
self-assembly in solution, and although it is often
utilized to monitor amyloid formation [38], it is not
specific for β-sheet structure or for amyloid [39,40].
ThT was excited at 440 nm, and its fluorescence
Fig. 3. Conformation and stability of ApoE isoforms. (a) Far UVCD spectra of ApoE isoforms (25 μM in 20mMPB, pH 7.4,
21 °C) showing comparable α-helical content. Secondary structure analysis was conducted with CONTIN/LL [32,33] at
DichroWeb [34–36] using the reference data set 6 [37], and results can be found in Table 3. (b) Intrinsic tryptophan
fluorescence (excitation at 295 nm) indicates that all three isoforms have a similar tertiary structure in PB. (c) Changes in
helical content were followed at 222 nm with increasing temperature. A Boltzmann sigmoidal equation was fitted to the data,
showing the order of stability E2 NN E3 N= E4 (i). The fraction unfolded of each protein calculated from the fitted curves was
also plotted against temperature (ii). Tm (°C) for each isoform, the temperature at which there was 50% change in α-helical
content, estimated from the fit denaturation curves can be found in Table 4a. Comparable α-helical content at 37°C were also
reported in Table 4a, and fraction unfolded at 37° C is shown in Table 4b. (d) GuHCl chemical denaturation of recombinant
ApoE isoforms plotted showing the wavelength of maximum fluorescence λmax at an excitation of 292 nm. Experimental data
points (closed circles) are shown. (i) A three-state unfolding model was fitted to the data; apparent midpoint GuHCl
concentrations can be found in Table 4b. (ii) Calculated fraction unfolded for each isoform from the fitted three-state unfolding
model is shown. ApoE2 (blue connective line), ApoE3 (green connective line), ApoE4 (red connective line).
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intensity was followed at 483 nm. The change in
fluorescence adjusted to baseline displayed a rapid
increase in intensity at 483 nm for ApoE4 (Fig. 4b(i and
ii)), and an extended lag phase for ApoE3 before any
changeswere detected (Fig. 4b(ii). Therewas very little
change in fluorescence for ApoE2 up to 24 h and only
minor increase up to 60 h (Fig. 4b). After a 3-day
incubation at 37 °C, the ThT fluorescence increased
further for ApoE4, while no further differences in ThT
intensity were observed for ApoE2 (Fig. S5). ThT
fluorescence data indicate fibrillization of ApoE4, while
onlyminor changes and no changeswere observed for
ApoE3 andE2, respectively. TEMwas used to observe
morphological changes with time. TEM of ApoE2
showed some small amorphous and some round
species after 24-h and 3-day incubation, respectively
(Fig. 4c). Small roundspecieswereobservedat 24h for
ApoE3 that increased in size over time and became
slightly elongated after 3-day incubation (Fig. 4c). In
contrast, ApoE4 showed fibrillar structures with a curvy
appearance at 24 h (Fig. 4c).
To further explore the assembly of ApoE4, TEMwas
used to monitor the size and morphology of the
assemblies at different time points up to 24 h. The
electron micrographs show accumulation of small
rounded species after only 1-h incubation. The
formation of short, curved filaments is detected by 3-h
incubation, which develop into curvy-linear filaments by
6 h and elongate into extended, curvy filaments by 24 h
(Fig. 5a). Measurement of the average length of the
filaments (Fig. 5b) confirms that the filaments extend in
length, while the diameter of the structures remains
invariant over 24 h, with an average length of 363 nm
and width of 30 nm (Fig. 5b and c). Close inspection of
the filamentous structures shows that they have a
granular appearance and do not share the twisted and
smooth appearance generally observed for amyloid
fibrils [41–43]. Fibril formation appears to arise from the
end-to-end fusion of the small spherical species,
making this unit the apparent smallest building block
of the structure.
CD and x-ray fiber diffraction experiments were
conducted to investigate the nature of ApoE4 fibrils
and to investigate whether these assemblies are
amyloid-like in structure and undergo the expected
conformational change to β-sheet [29]. CD spectra
collected for ApoE4 fibrils incubated for 24 h showed
a spectrum with minima at 208 and 222 nm
consistent with a predominantly α-helical secondary
structure content (Fig. 5d), of comparable shape and
intensities to that of non-assembled ApoE4 (Fig. 3a).
To ensure that any remaining soluble protein does
not dominate the spectra, the sample was centri-
fuged at high speed to separate supernatant and
pellet fractions. The CD data for the resolubilized
pellet fraction show that E4 retains its α-helical
structure after incubation at 37 °C for 24 h, and that
there is almost no soluble protein left given the very
small CD signal in the supernatant fraction (Fig. 5d).
The fiber pellet was sonicated to ensure that protein
was resuspended sufficiently and the spectrum
continued to demonstrate α-helical content.
To examine the molecular structure of the mature
ApoE4 filaments, 100 μM ApoE4 was incubated for
24 h and aligned to form a partially-aligned fiber
Table 3. Secondary structure analysis of recombinant
ApoE isoforms from CD spectroscopy dataa
α-Helix
(%)
β-Strand
(%)
β-Turn
(%)
Random coil
(%)
NRMSD
(%)
ApoE2 57.3 3.5 14.1 25.3 0.0178
ApoE3 59.5 3.3 13.0 24.2 0.0190
ApoE4 58.4 3.4 13.5 24.7 0.0184
The normalized root mean square deviation (NRMSD) is an
estimate of the goodness-of-fit (NRMSD b 0.1 is a necessary but
not sufficient condition.
α-helical content was similar between the three ApoE isoforms
(within experimental error).
a Calculated by CONTIN program at DichroWeb (http://
dichroweb.cryst.bbk.ac.uk/html/home.shtml).
Table 4a. Thermal denaturation parameters from
Boltzmann sigmoidal equation curve
Tm (°C) [Θ]222 nm at 37 °C (deg cm
2 dmol−1)
ApoE2 60.28 ± 1.18 −19181 ± 649
ApoE3 52.39 ± 1.92 −19809 ± 961
ApoE4 51.32 ± 4.32 −19092 ± 773
Tm (°C) represents the temperature at which there was 50%
change in α-helical content.
Non-linear best-fit parameters were determined on GraphPad
Prism.
Table 4b. Fraction unfolded of ApoE at 37 °C
Fraction unfolded at 37 °C %Fraction unfolded
ApoE2 0.1 ± 0.07 10
ApoE3 0.13 ± 0.03 13
ApoE4 0.17 ± 0.06 17
Fraction unfolded of ApoE at 37°Cwas calculated from the fraction
unfolded curves given by Eq. (7) (Fig. 3c). Non-linear best-fit
parameters were determined using GraphPad Prism.
Table 4c. Chemical denaturation parameters from double
sigmoidal curve
[GuHCl]50,I (M) [GuHCl]50,U (M)
ApoE2 0.69 ± 0.03 2.84 ± 0.04
ApoE3 0.71 ± 0.03 2.66 ± 0.07
ApoE4 0.58 ± 0.04 2.65 ± 0.08
[GuHCl]50, I is the concentration needed for 50% of the protein to
unfolded to an intermediate state. [GuHCl]50, U is concentration
needed for 50% of the intermediate state to reach the unfolded
state. Non-linear best-fit parameters were determined using
GraphPad Prism.
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Fig. 4. Self-assembly of ApoE4 but not ApoE2 or ApoE3. (a) Native gel shows the formation of higher oligomeric
species for ApoE4 (N1048 kDa) but not E2 and E3 after incubation at 37°C for 24 h. (b) Kinetics of ApoE self-assembly
(ApoE2, blue; ApoE3, green; ApoE4, red) was monitored by recording changes in ThT fluorescence intensity at 483 nm
over 3 days. A comparison between the three isoforms was established by looking at adjusted ThT fluorescence. Changes
in ThT fluorescence varied with each isoform, with a faster increase observed for ApoE4. After 3 days, ApoE3 and ApoE4,
but not ApoE2, show changes in ThT fluorescence (top panel). The bottom panel is a close-up on the first 24 h of assembly.
The length of the lag phase was different for each isoform, with ApoE2 N ApoE3 NN ApoE4. Envelopes correspond to the
standard error of the mean (SEM). (c) TEM of negatively stained ApoE isoforms after incubation for 24 h (left side) and 3
days (right side) at 37 °C shows no fibril formation of ApoE2 and ApoE3. ApoE4 self-assembles to form long, curved fibrils.
ApoE3 formed round oligomeric species after a 3-day incubation. The scale bars represent 500 nm.
Fig. 5. Characterization of ApoE4 fibrils. (a) Transmission electron micrographs of negatively stained ApoE4 (25 μM in
20 mM PB, pH 7.4) monitored over 24 h at 37 °C. The scale bar represents 200 nm. ApoE4 self-assembly was
characterized by measuring changes in length (b) and width (c) of the fibrils. Changes in width were non-significant;
however, with increasing incubation times, ApoE4 fibrils become significantly longer (average length of 363 nm; one-way
ANOVA: ****p b 0.0001, F = 180.9). (d) CD spectra show retention of α-helical secondary structure after assembly (whole
fraction). Fibrils in the pellet were separated from the supernatant to confirm that their secondary structure is not masked
by protein in the supernatant. Fibrils in the pellet showed an α-helical conformation. (e) X-ray fiber diffraction pattern
obtained from partially aligned ApoE4 fibrils after 24-h incubation at 37 °C showing positions of diffraction signals on the
meridian (vertical) and equatorial (horizontal) axes.
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bundle. The x-ray fiber diffraction pattern showed a
sharp meridional diffraction signal at 4.5 Å with a
weaker diffraction signal at 4.1 Å. On the equator, a
diffuse, strong signal was observed at 10.1 Å and a
weaker reflection at approximately 21 Å (Fig. 5e).
Comparison of the relative intensities shows that the
meridional reflections are weaker than those on the
equator, which is dissimilar to those usually ob-
served for amyloid fibril patterns where signals arise
from cross-β structure at 4.7 and 10 Å on perpen-
dicular axes [44]. The diffraction data obtained
support the CD data described above, showing
that the ApoE4 retains an α-helical conformation in
the fibers, which is similar to the structure in the
soluble protein.
ApoE3 and ApoE4 influence the assembly of one
another
ApoE4 alone is able to self-assemble to form non-
amyloid-like filaments. However, the majority of indi-
viduals with an ε4 allele are heterozygous and have an
ε3 allele. To investigate the influence of ApoE3
presence on ApoE4 assembly and vice versa, ApoE3
was incubated with ApoE4 over the course of 24 h to
investigate whether they could enhance/seed or inhibit
assembly. ApoE3 and ApoE4 were each at 12.5 μM to
give a combined ApoE concentration of 25 μM.
Assembly over time was compared to assembly of
ApoE3 or ApoE4 alone at 12.5 μM (not shown) or 25
μM. Figure 6a shows that ApoE3 reduced the rate of
assembly of ApoE4, measured by ThT fluorescence;
the ThT kinetics of the mixed sample did not resemble
that of E3 alone either. TEM micrographs were
produced for the mixed sample and showed the
presence of small round and small amorphous species
instead of the long mature fibrils observed for ApoE4
alone (Fig. 6b).
Discussion
The manner in which APOE genotype leads to an
increased risk for late-onset AD remains unclear.
Some studies have proposed that the three ApoE
isoforms differ in their structure and consequently
function, which may explain ApoE4's differential
effects on AD pathogenesis [3,45]. Modeling and
fluorescence resonance energy transfer studies
have been used to provide evidence of a more
open conformation for ApoE4 compared to ApoE3
[11,46,47], suggesting that the N-terminal region of
Fig. 6. ApoE3 inhibits ApoE4 fibril formation. (a) Adjusted ThT fluorescence at 483 nmwas monitored over the course of
24 h, 37 °C for ApoE3 alone (25 μM), ApoE4 alone (25 μM) and ApoE3 plus ApoE4 (both 12.5 μM for a total ApoE
concentration of 25 μM) in PB (pH 7.4). (b) Transmission electron micrographs showed a heterogeneous population, with
the presence of small round and small amorphous species, but no mature fibrils when E4 is incubated with E3 in a 1:1 ratio.
The scale bar represents 500 nm.
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ApoE4 is less well tethered to the C-terminal domain
than for ApoE3. Others have pointed to differences in
stability and conformation [29,48] and havesuggested
that ApoE4 is less stable and more prone to
aggregation to form amyloid-like fibrils [29]. In vivo,
ApoE is glycosylated and also lipidated [49]. While we
have explored the structural conformations adopted
by recombinant non-modified ApoE, previous studies
have shown that the recombinant ApoE produced in
Escherichia coli adopts a very similar conformation
and folding to protein produced in adenovirus [50].
Further studies will be necessary to explore the
behavior of lipidated proteins.
Here we have investigated the size, oligomerization
state and shape of recombinant ApoE isoforms in
aqueous solution. Our results are in agreement with
previous observations [51] and confirm that all three
isoforms form an elongated tetramer in solution. SAXS
data provides additional information regarding the low-
resolution structure of ApoE isoforms in solution and
validates the elongated shape in solution with ApoE
qualitatively resembling multiple domains that are
tethered by flexible linkers. Identical x-ray scattering
profiles between ApoE isoforms suggest no major
structural differences in macromolecular architecture.
CD reveals that all three isoforms share a similar α-
helical content at physiological pH, when measured at
21 °C. This is in contrast to other studies, which have
reported differences in α-helical content between the
isoforms at 15° C, with ApoE4 being the least α-helical
protein [48]. Here, temperature and chemical denatur-
ation studies revealed very small differences in stability
towards unfolding for the three isoforms.Melting curves
displayed a sigmoidal shape that is characteristic for
two-state unfolding, with Tm(E2) ≥ Tm(E3) ≈ Tm(E4),
which is in agreement with previously reported results
in terms of order of stability [25,48,52]. However, it is
also important to highlight that all three isoforms have
the very similar secondary structure content and
fraction unfolded at physiological temperature of 37 °C.
Chemical denaturation displayed multi-phasic
unfolding curves for all three isoforms, consistent with
the independent unfolding of the C-terminal and N-
terminal domains as described by Morrow and
colleagues [25]. While the curves cannot be used to
fully deduce ΔG°H2O and the slope m-value for each
transition since the three-state model employed is
empirical in this case, we interpret slight differences in
the apparent denaturant concentration corresponding
to themidpoint of each transitions.On theonehand, the
transition from the folded to intermediate statewas very
similar for ApoE2 and ApoE3; however, it occurred at a
lower denaturant concentration for ApoE4.On theother
hand, transitioning from intermediate to unfolded was
most similar between ApoE3 and ApoE4, whereas
ApoE2 required a slightly higher denaturant concen-
tration. Others have gone further with chemical
denaturation studies by looking at the 10 kDa carboxy-
and the 22 kDa amino-terminal domains, in conjunction
to the corresponding full-length proteins. Data resulted
in the attribution of the first transition to the unfolding of
the 10-kDa carboxy fragment and the second to that of
the 22-kDa amino-terminal domain, while reporting the
same order of chemical stability [25,48,53].
The loss of stability of ApoE4 as measured by
spectroscopic methods, albeit under extreme condi-
tions such as high temperature or under denaturing
conditions, may be related to its propensity to
polymerize into filamentous structures. We showed
here that ApoE4 forms filamentous structures after only
24-h incubation at physiological temperature, pH 7.4,
whileApoE2andApoE3 remainedsoluble andglobular
under the same conditions. TEM reveals that the
ApoE4 filaments have a polymeric appearance (beads
on a string), and there is a clear hierarchical assembly
of small spherical species to small, elongated fibrils and
finally fibrils, which show identical diameters.CDshows
that following incubation, the ApoE4 fibers retain their
α-helical secondary structural content. The CD for the
whole fraction is almost identical to ApoE4 prior to
incubation. To probe whether the α-helical intensity
arises from soluble, unassembled protein, we exam-
ined theCD froma sedimented sample. Both pellet and
supernatant fractions show a spectrum consistent with
high α-helical content. Furthermore, the intensity of the
spectrum in the supernatant was very low, suggesting
that themajority of theApoE4protein is foundwithin the
fiber containing pellet. This result contrasts with a small
shift from α-helix to β-sheet previously described by
Hatters et al. [29]. ThT fluorescence assay shows
increasing intensity at 483 nm with time showing that
the fibril formation course can be followed using this
chemical rotor [39,40]. Although ThT is well character-
ized as fluorescent probe for amyloid fibril formation, it
is amolecular rotor that is not specifically sensitive to β-
sheet structures. Amyloid binding studies have re-
vealed that ThT may associate with aromatic groups
including tyrosine ladders [54,55]. Fluorescence inten-
sity can increase in the presence of many polymeric
molecules and in viscous solutions [54]. Furthermore,
ThT is fluorescent in the presence of cross-α fibrous
molecules revealing that its fluorescence does not rely
on β-sheet structure [56].
X-ray fiber diffraction has been classed as a definitive
diagnostic for amyloid fibrils, giving the classical
amyloid cross-β diffraction pattern composed of a
4.76-Å meridional arising from hydrogen bonding β-
strands running perpendicular to the fiber axis and a
more diffuse equatorial signal that arises from β-sheet
packing that accommodates side chains [57–59]. Here
we revealed that the ApoE4 filaments do not give a
cross-β pattern, instead diffraction shows a pattern that
can be interpreted as α-helical rich polymer, consistent
with the TEM and CD data. An α-helix has a repeat of
5.4 Å parallel to the axis of the helix (1.5 Å rise per
residue, with 3.6 residues/turn) [60]. However, the
structure of the ApoE molecule is not arranged with all
helices arranged in a vertical array. 4.5 Å is a repeating
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unit along an extended polypeptide chain and was
previously observed for dried peptide crystals [61],
while 10 .1 Å approximates to the packing of helices in
the vertically aligned ApoE structure. Furthermore,
amyloid fibrils are characterized by their high stability
and resistance to degradation. For example, amyloid
formed by the Alzheimer's-related peptide is SDS
resistant [62]. ApoE4 fibrils run as a monomer by SDS
page (data not shown) and the ApoE4 species run on a
native gel at similar mobility to ApoE3 and ApoE2.
Many examples of native like polymers exist including
pathologically related serpins such as α-1-antitrypsin
[63] and functional polymeric proteins such as micro-
tubules and actin.
The majority of individuals are heterozygous ε3/ε4,
and this confers an increased risk for AD develop-
ment, albeit lower than for ε4/ε4 individuals [64].
Here we investigated the aggregation potential for
mixed population of ApoE3 and ApoE4 and revealed
that E3 inhibits E4 fibril formation in vitro, leading to a
mid-range aggregation kinetic for assembly. There-
fore, the increased dose of ApoE4 in ε4/ε4 individ-
uals leads to increased assembly compared to half
dose of ApoE4 in those who posses ε3/ε4.
Conclusions
The detailed studies conducted have revealed that
recombinant ApoE2, ApoE3 and ApoE4 resemble one
another at quaternary, tertiary and secondary structural
levels. All three ApoE isoforms form elongated
tetramers in solution, and each monomer is rich in α-
helical conformation. There is no evidence that the
aqueous proteins differ at a structural level. Further-
more, chemical and thermal denaturation studies
reveal that the three proteins are similarly stable and
follow comparable unfolding mechanisms by melting
and by chemical denaturation. However, we have
shown that ApoE4 has a higher propensity for
polymerization at physiological temperature and pH,
to form elongated fibrous structures which retain the
native α-helical conformation. The propensity of ApoE4
to self-assemble may play an important role in the
mechanism by which it increases susceptibility to
develop AD, which impacts on ε4/ε4 individuals more
severely than those with ε3/ε4.
Materials and Methods
All materials were purchased from Sigma-Aldrich
or Fisher Scientific at the highest purity available.
Protein production
ApoE2, ApoE3 and ApoE4 were cloned, expressed
and purified using methods detailed in the supplemen-
tary information. Briefly, a codon-optimized ApoE4
gene was cloned into a pET17b vector with a six-
histidine tag, thioredoxin and HRV 3C protease
cleavage site upstream. ApoE2 and ApoE3 genes
were generated by site-directed mutagenesis using
QuikChange (Agilent). Recombinant ApoE proteins
were expressed in E. coli Rosetta2(DE3) cells and
affinity purified using Talon® beads followed by HiTrap
heparin affinity column and cleaved on column with
PreScission protease. The ApoE proteins were eluted
using a salt gradient and further purified using aHiLoad
Superdex 26/600 200 pg size exclusion column. ApoE
containing fractions were concentrated and stored at -
80 °C.
Gel filtration studies
The high-molecular-weight protein standard (GE
Healthcare, no. 28-4038-42) was used to calibrate the
HiLoad Superdex 26/600 200 pg column (GE Health-
care). All protein standards and dextran blue were
dissolved in SEC buffer [20 mMHepes, 300 mMNaCl,
10% (v/v) glycerol (pH 8.0)] according to the manufac-
turer's recommended concentrations (0.4 mg/mL
ferritin, 4 mg/mL aldolase, 3 mg/mL conalbumin, 3
mg/mLovalbumin), and1.6mLof theprotein calibration
mixture was applied onto the column at a flow rate of
1.5 mL/min. Stokes radius (size) values were calculat-
ed on the basis of ApoE elution volume (Eq. (1))
Kav ¼
Ve−V0
V t−V0
ð1Þ
where Ve = elution volume for the protein, V0 =
Superdex 200 void volume (112.26 mL), and Vt =
total Superdex 200 bed volume (320 mL). Kav values
were calculated for each protein standard and a
standard curve generated by plotting the √(− log(Kav))
as y values versus theStoke radiusof eachstandardas
x values (ferritin 6.1 nm, aldolase 4.8 nm, conalbumin
4.04 nm, ovalbumin 2.75 nm). ApoE Stoke radius RS
was estimated with the following best fit linear Eq. (2):
y ¼ 0:1058 x þ 0:2397 R2 ¼ 0:9552
 
ð2Þ
ApoE diffusion coefficient Dwas estimated from its
Stoke radius RS by the following Eq. (3):
D ¼
kT
6piηRs
ð3Þ
where k is the Boltzmann constant (1.38 × 10−23 m2
kg s−2 K−1), T is the experimental temperature
(277.15 K) and η is the solvent viscosity (1.4181 ×
10−3 Pa s) at temperature T.
The frictional ratio f/f0 = RS/Rmin was calculated by
assuming the minimal radius (Rmin) of a sphere that
could contain the given mass of tetrameric ApoE
(136,800 Da), where Rmin [31] is defined as
Rmin ¼ 0:066 M
1
3 for M in Dalton;Rmin in nmð Þð4Þ
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Dialysis and buffer exchange
ApoEwas either extensively dialysed overnight in 20
mM PB (16 mM Na2HPO4, 4 mM NaH2PO4) at pH 7.4
using Slide-A-Lyzer™ Dialysis Cassettes with a
molecular weight cutoff (MWCO) of at 3.5 kDa (Thermo
Fisher) or buffer exchanged using disposable Vivas-
pin® 500 centrifugal concentrators with an MWCO of 3
kDa or Vivaspin® 20 centrifugal concentrators with an
MWCO of 3 or 10 kDa (Sartorius).
Gel electrophoresis
Protein samples for denaturing one-dimensional
SDS–gel electrophoresis were prepared in Laemmli
sample buffer (Bio-Rad) to a final concentration of 3
μM, omitting the addition of any reducing agent.
Samples were loaded into a 4%–20% TGX gel (Bio-
Rad), and the gel was run at 120 V (constant voltage)
for 80 min. Resolved proteins were stained using a
Coomassie dye R-250 containing solution (Imperial
protein stain, no. 24615; Thermo Scientific).
Protein samples for native PAGE were diluted to 3
μM in native sample buffer (Bio-Rad) and were directly
loaded into a 4%–20% TGX gel (Bio-Rad). Gels were
run at 120V for 120 min. Resolved proteins were
stained using a Coomassie dye R-250 containing
solution.
SAXS and SEC-MALS
SAXS and MALS experiments were performed at
the B21 beamline (Diamond Light Source, UK).
X-ray scattering was acquired with an x-ray
wavelength of 1 Å on a Pilatus 2M detector at a
distance of 3.9 m and a camera length of 4.036 m.
ApoE isoforms at 10 mg/mL were delivered at 20 °C
and a flow rate of 0.16 mL/min via an in-line Agilent
high-performance liquid chromatography with a
Shodex Kw-403 column and 20 mM Hepes and
300 mM NaCl (pH 8.0) as running buffer. In total, 620
frames were recorded and each frame exposed for 3
s. Buffer subtraction and averaging was performed in
ScAtter version 3.1R. Data was analyzed in ScAtter
version 3.1R and ATSAS 2.8.2 for comparison.
ApoE isoforms were diluted to 5 mg/mL in 20 mM
Hepes, 300 mM NaCl and 1 mM TCEP (pH 8.0) for
MALS experiments and delivered at RT via an in-line
Agilent high-performance liquid chromatography with a
Shodex Kw-403 column. Refractive increments (dn/dc)
were determined by a Wyatt optilab T-rEX and
scattering measured by a Wyatt Dawn Heleo with
QELS.Datawere analyzed usingASTRAversion 6.1.7
(Wyatt).
AUC
Sedimentation velocity experiments were carried
out in a Beckman model XL-A analytical ultracentri-
fuge (Beckman Coulter, Fullerton, CA) at 20 °C using
an AnTi60 rotor. ApoE isoforms (400 μL) were used
at a concentration of 8 μM in 20 mM Hepes, 300 mM
NaCl and 10% (v/v) glycerol (pH 8.0) or at a
concentration of 8 μM in 20 mM PB (pH 7.4).
Experiments were performed at a rotor speed of
40,000 rpm (128,794g), and absorbance at 280 nm
was recorded every 25 min, at radial intervals of
0.003 cm. A continuous size c(S) distribution c(S)
from the Lamm equation model in the range of 0.1S–
15S was fit to the data using the program SEDFIT
version 15.01b [65]. The confidence interval (F-ratio)
was set to 0.95. Buffer viscosity and density were
calculated in Sednterp version 20120828 BETA [66].
CD spectroscopy
ApoE isoforms were diluted to a final concentration
of ~25 μM in 20 mM PB (pH 7.4). The exact
concentrations were confirmed in triplicate using a
NanoDrop ND2000c spectrophotomer (Thermo
Fisher) by measuring the absorbance at 280 nm
and applying Beer-Lambert's law using an extinction
coefficient of 44,460 L mol−1 cm−1 The averaged
concentrations were recorded and used in calcula-
tions when needed.
FarUV CD data were collected using a Jasco-715
CD-spectrometer (Jasco, Goh-Umstadt, Germany)
at different time points. Temperature was maintained
at 21 °C using a Peltier controlled cell holder. All
spectra were collected in 0.01-cm transparent quartz
cuvettes (Starna Scientific, Essex, UK) in the range
of 280–180 nm with a resolution of 0.1 nm and a
bandwidth of 1 nm. Scanning speed was set to 50
nm/min, response time to 4 s and sensitivity to
standard. Three spectra per sample were acquired
and averaged to give a spectrum after subtracting
blank spectra of the buffer. For each isoform, spectra
were collected on protein from at least three different
production batches and an average trace of [Θ]
against wavelength was obtained using GraphPad
Prism. The mean residue ellipticity ([Θ] in deg cm2
dmol−1) was calculated from the measured ellipticity
Θ in mdeg at wavelength λ using Eq. (5):
Θ½  ¼
Θ
10:n:C:l
ð5Þ
with n the number of amino acid bonds in the protein,
C the concentration of the sample in mol L−1 and a
path length of 1 cm.
Secondary structure of ApoE isoforms was calcu-
lated by deconvolution of CD spectra performed with
CONTIN/LL [32,33] at DichroWeb [35] using the
reference spectra set 6 [37]. Results represent a
mean of values from a minimum of three spectra per
isoform. One-way ANOVA was performed to com-
pare the α-helical content between the isoforms,
using GraphPad Prism.
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Thermal denaturation using CD
ApoE isoformswere diluted to a final concentration of
~25 μM in 20 mMPB (pH 7.4). CD data were collected
using a Jasco-715 CD-spectrometer (Jasco, Goh-
Umstadt, Germany). Temperature was increased at a
rate of 1°C/min from 20 °C to 80 °C using a Peltier-
controlled cell holder. Thermal scans were acquired at
awavelength λ of 222 nmevery 1.0 °Cwith a sensitivity
of 100mdeg, a response time of 1 s and a bandwidth of
1 nm. Thermal scans were acquired for proteins
purified from at least three different production batches,
and an average trace of [Θ] against temperature was
obtained using GraphPad Prism. The unfolding was
irreversible. A phenomenological Boltzmann sigmoidal
curve with the following Eq. (6) was fitted to the
averaged thermal denaturation curves:
Y ¼
Top−Bottom
1þ e
Tm−X
Slope
ð6Þ
with Top = maximum Θ value, Bottom = minimum Θ
value, Tm the temperature corresponding to 50%
change in α-helical content and Slope = the steepness
of the curve. The calculated thermal denaturation curve
basedon the fitted curveswasalso transformed into the
fraction of the protein unfolded for comparison of
protein transformation with the following Eq. (7):
Fraction unfolded ¼
Θ½ N− Θ½ 
Θ½ N− Θ½ D
ð7Þ
with [Θ]N the ellipticity of the protein at 20 °C
corresponding to the folded state and [Θ]D the ellipticity
of the denatured protein at 80 °C.
Intrinsic fluorescence measurements
Recombinant ApoE isoformswere diluted to 10μM in
20 mM PB and incubated overnight at 4 °C. Fluores-
cence scans were acquired using SpectraMax i3
reader (Molecular dimensions). Excitation was set to
295 nm, and scans were collected with 1-nm incre-
ments between 320 and 465 nm. Excitation and
emission bandwidths were set to 9 and 15 nm,
respectively. The number of reading per well was set
to 6. The photomultiplier tube voltage was set to high.
Blank spectra of the buffer were subtracted to protein
fluorescence scans. A minimum of three different
production batches per isoform were used, and an
average trace of fluorescence intensity against wave-
length was obtained using GraphPad Prism.
Chemical denaturation and data analysis
Recombinant ApoE isoforms at ~0.05 mg/mL in 20
mM PB and 1 mM dithiothreitol were incubated
overnight at 4 °C with increasing concentrations of
GuHCl (0–6M) [25].Measurementswere obtainedwith
a Varian Cary Eclipse spectrophotometer (Varian Ltd.,
Oxford, UK) and quartz cuvette (1-cm path length;
Starna,Essex,UK). Temperaturewasmaintainedat 20
°C using a Varian Cary temperature controller.
Tryptophan residues were selectively excited at
292 nm and emission was monitored between 310
and 400 nm; excitation and emission slits were set to
10 nm. Five acquisitions per concentration point
were acquired at a scan speed of 90 nm/min using
response time of 0.05 s. A minimum of three different
production batches per isoform were used [67].
Wavelength of maximum emission (λmax) per
GuHCl point was determined by peak fitting of the
averaged emission spectra [48]. Denaturation
curves were obtained by plotting the wavelength
corresponding to the maximum fluorescence inten-
sity against GuHCl concentration ([GuHCl]) on
GraphPad Prism. The curves show two major
transitions and can be described by a three-state
unfolding model [68], as described in Eqs. (8) and (9)
Folded⇆Intermediate⇆Unfolded ð8Þ
Y ¼
Y F GuHCl½ ð Þ þ YU GuHCl½ ð Þ  K app
1þ K app
ð9Þ
Equation (9) [68] was fitted to the data with Y
corresponding to λmax, and YF and YU the signal
corresponding to the folded (F) and unfolded (U)
protein, respectively. YF and YU are assumed to be
linearly dependent on the concentration of denatur-
ant, as displayed in Eq. (10):
Y X ¼ Y
0
X þmx GuHCl½  ð10Þ
with X corresponding to either the F or U state and
Yx
0 the λmax at either 0 M GuHCl or 6 M. In Eq. (9),
Kapp corresponds to the apparent guanidine-depen-
dent equilibrium constant of the denaturation pro-
cess, defined by Eq. (11):
K app ¼
K 1K 2 þ AK 1
1þ 1−Að ÞK 1
ð11Þ
K1, K2 and A are defined by Eqs. (12)-(14)
K 1 ¼ e
− ∆G1H2O−m1 GuHCl½ ð Þ
RT ð12Þ
K 2 ¼ e
− ∆G2H2O−m2 GuHCl½ ð Þ
RT ð13Þ
A ¼
Y i−Y
0
F
 
Y 0U−Y
0
F
  ð14Þ
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A, m1 and m2 were the fitted parameters, while
ΔG°1H2O and ΔG°2H2O are the linearly extrapolated
free energy differences at 0 MGuHCl [68] F to I, and I
to U, respectively. Subsequently, the concentrations
corresponding to 50% unfolding of the protein to an
intermediate state ([GuHCl]50, I) and to an unfolded
state ([GuHCl]50, U) were calculated by Eqs. (15) and
(16) and compared:
GuHCl½ 50;I ¼
∆GÅ1H2O
m1
ð15Þ
GuHCl½ 50;U ¼
∆GÅ2H2O
m2
ð16Þ
The fraction unfolded, A, was also calculated and
plotted as a function of [GuHCl] to facilitate
comparison of the shape of the unfolding curves
between the three isoforms.
ThT fluorescence assay of ApoE self-assembly
ApoE isoforms at ~25 μM in 20 mM PB (pH 7.4)
were incubated in the presence of ThT at 37 °C in the
SpectraMax i3 plate reader. Aqueous ThT stock
solution was prepared at a concentration of 3.14
mM, filtered through a 0.2-μm pore size and used in
a 1:2.2 ratio. Ninety-six-well plates were sealed with
an optically clear polyolefin film to avoid evaporation
(StarSeal Advanced Polyolefin Film, Starlab). The
number of reading per well was set to 6, PMT voltage
was set to high and blank spectra of the buffer were
subtracted to protein fluorescence scans. Excitation
wavelength was 440 nm, and emission at 483 nm
was monitored every 15 min, with 3-s low orbital
shakes before readings. Fluorescence intensity at a
given time point (F) for each isoform was adjusted by
subtracting the minimum fluorescence intensity
value (Fmin), and not to the initial fluorescence, to
account for the increasing temperature effect on ThT
(from room temperature to 37 °C).
Adjusted fluorescence was plotted against time,
and averaged traces for each isoform were obtained
on GraphPad Prism. A minimum of three different
production batches per isoform were used.
Negative-stain transmission electron micro-
scopy (TEM)
Morphology of ApoE after 24-h incubation at 37 °C
was assessed by negative stain TEM. A droplet of
sample (4 μL) was placed on 400-mesh carbon-
coated grids (Agar Scientific, Essex, UK) and
incubated for 1 min. After blotting the excess
solution, the grid was washed with 4 μL filtered
Milli-Q water and blotted. It was then negatively
stained with 4 μL filtered 0.5% uranyl acetate for 40 s
and blotted with filter paper. Grids were left to air-dry
for at least 5 min before storage. Grids were
examined on a Jeol Jem1400-plus transmission
electron microscope (Jeol, USA) operated at 80 kV
fitted with a Gatan Orius SC100 camera (UK).
Separation of fibril pellet from supernatant
To probe the secondary structure of ApoE4 fibrils,
pellets were isolated from supernatant by ultra-
centrifugation of assembled fibrils at 60,000 rpm in
an OptimaTM MAX Ultracentrifuge (Beckman Coul-
ter) using a Beckman TLA120.2 fixed-angle rotor for
45 min at 4 °C. Supernatant was removed and
replace by fresh 20 mM PB buffer. CD spectra of the
whole fraction, supernatant, pellet and sonicated
pellet (5-s sonication) were acquired as described for
CD. The data were plotted graphically using Graph-
Pad Prism but without conversion to molar ellipticity.
Data for whole fraction, pellet and supernatant for
the same sample were compared directly to com-
pare secondary structure and protein content for
each fraction.
X-ray fiber diffraction
ApoE4 (100 μM in PB, pH 7.4) was incubated for
24 h at 37 °C to form fibrils and then the sample was
centrifuged for 40 min at 21,100 rpm at 4 °C using a
benchtop centrifuge (Mikro 22R, Hettich). The
resulting pellet was resuspended in 400 μL filtered
milliQ water, and this was repeated to remove salts
that could interfere with the diffraction pattern.
Finally, the pellet was resuspended in 30 μL filtered
milliQ water. Ten microliters of concentrated fiber
sample was suspended between two wax-filled
capillaries and incubated in a sealed Petri dish at
4°C to form a partially aligned fiber sample [69].
X-ray diffraction images were collected using a
Rigaku rotating anode source (CuKα) and a Saturn
CCD+ detector. Partially aligned fibers were placed
in the x-ray beam and exposed for 30 or 60 s at
specimen to detector distances of 50 and 100 mm.
Diffraction patterns were converted to TIFF format
using imosflm [70] and analyzed using CLEARER
[71].
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